Aimovig vs. Emgality
- Are Aimovig and Emgality the Same Thing?
- What Are Possible Side Effects of Aimovig?
- What Are Possible Side Effects of Emgality?
- What Is Aimovig?
- What Is Emgality?
- What Drugs Interact with Aimovig?
- What Drugs Interact with Emgality?
- How Should Aimovig Be Taken?
- How Should Emgality Be Taken?
Are Aimovig and Emgality the Same Thing?
Aimovig (erenumab-aooe) and Emgality (galcanezumab-gnlm) are calcitonin gene-related peptide receptor antagonists indicated for the preventive treatment of migraine in adults.
What Are Possible Side Effects of Aimovig?
Common side effects of Aimovig include:
- injection site reactions (pain or redness),
- constipation, and
- muscle spasms or
- cramps
What Are Possible Side Effects of Emgality?
Common side effects of Emgality include:
- injection site reactions such as pain, redness, and itching
What Is Aimovig?
Aimovig (erenumab-aooe) Injection is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults.
What Is Emgality?
Emgality (galcanezumab-gnlm) is a calcitonin-gene related peptide antagonist indicated for the preventive treatment of migraine in adults.
What Drugs Interact With Aimovig?
Aimovig may interact with other drugs. Tell your doctor all medications and supplements you use.
What Drugs Interact With Emgality?
Emgality may interact with other drugs. Tell your doctor all medications and supplements you use.
How Should Aimovig Be Taken?
The recommended dosage of Aimovig is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly, which is administered as two consecutive subcutaneous injections of 70 mg each.
How Should Emgality Be Taken?
The recommended dosage of Emgality is a 240 mg loading dose (administered as two consecutive injections of 120 mg each), followed by monthly doses of 120 mg.